The finding i n Sanfilippo syndrome type D (N-acetylglucosamine-6-sulfatase deficiency) t h a t Hex A can bypass the blockage i n keratan s u l f a t e degradation by cleavage en bloc of B-N-acetylglucosamine-6-sulfate, l e d t o the present approach. 4-methylumbelliferyl d e r i v a t i v e s of 0-N-acetylglucosamine-6-sulfate (MUBGlcNAc-6-S) and 0-N-acetylgalactosamine-6-sulfate (MUBGalNAc-6-S) were prepared from t h e commonly used unsulfated d e r i v a t i v e s . Sera (n=5), leukocytes (n=3) and f i b r o b l a s t s (n=2) from p a t i e n t s with Tay-Sachs d i s e a s e (TSD) demonstrated markedly d e f i c i e n t act i v i t i e s toward both s u l f a t e d s u b s t r a t e s , 2-4% of c o n t r o l a c t i v it i e s (n=12), and samples from o b l i g a t e heterozygotes f o r TSD (n=4) had intermediate a c t i v i t y values, 43-62% of c o n t r o l a c t i v it i e s . Fibroblasts (n=2) from p a t i e n t s with Morquio syndrome type A (N-acetylgalactosamine-6-sulfatase deficiency) had normal act i v i t i e s toward both s u l f a t e d s u b s t r a t e s but the c h a r a c t e r i s t i c urinary excretion of chondroitin s u l f a t e i n t h i s d i s e a s e , indic a t e s t h a t t h e r e i s no analogy with Sanfilippo syndrome type D and Hex A is incapable of cleaving en bloc BGalNAc-6-S from t h e n a t u r a l s u b s t r a t e . I n c o n t r a s t t o n a t u r a l s u b s t r a t e s , t h e synt h e t i c s u l f a t e d s u b s t r a t e s a r e both s p e c i f i c f o r Hex A and thus, can provide d i r e c t and simple methods f o r diagnosis as well a s f o r a n t e n a t a l and c a r r i e r d e t e c t i o n of TSD. UDP-N-acetylglucosamine (UDP-GlcNAc) is t h e donor of N-acetylglucosaminyl-1-phosphate (GlcNAcP) i n t h e r e a c t i o n catalyzed by GlcNAcP t r a n s f e r a s e , t h e enzyme d e f i c i e n t i n p a t i e n t s with I -c e l l d i s e a s e (ICD) and pseudo-Hur e r po dystrophy (PHPD). The use of 3 commercially a v a i l a b l e UDP-[ H o r "CIGlcNAc r a t h e r than the synt h e t i c a l l y made [ B -~~P ] U D P -G~C N A~ was inadequate because of high background. We have overcome t h i s i n t h e assay of GlcNAcP t r a s f er a s e with a-methylmannoside acceptor by removal of f r e e [ 3~ o r 1 4~~~~c~~c which appeared t o be t h e major breakdown product. I n addition, t h e a-methylmannose-6-phospho-1-[% or 1 4~]~l c~~c product of t h e t r a n s f e r r e a c t i o n was then i s o l a t e d and following des a l t i n g could be used a s a s u b s t r a t e f o r t h e assay of aGlcNAc phosphodiesterase. Using t h e s e r e l a t i v e l y simple methods, deficiency of GlcNAcP t r a n s f e r a s e a c t i v i t y could be demonstrated i n f i b r o b l a s t s from p a t i e n t s with t h e c l a s s i c a l forms of ICD (n=4; l e s s than 4% of c o n t r o l a c t i v i t y ) and PHPD (n=4; 3-33% of c o n t r o l a c t i v i t y ) . aGlcNAc phosphodiesterase a c t i v i t y was within t h e normal range. I n c o n t r a s t , i n t h r e e r e l a t e d a d u l t p a t i e n t s with what appears t o be a very mild form of PHPD, both a c t i v i t i e s were normal and u t i l i z a t i o n of n a t u r a l lysosomal enzyme acceptor (%-glucuronidase) was required t o r e v e a l deficiency of GlcNAcP t r a n s f er a s e a c t i v i t y .
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INBORN ERRORS OF UREAGENESIS;
RESULTS OF t 746 THERAPY I N 4 4 PATIENTS. S a u l B r u s i l o w . J o h n s H o p k i n s D e p t . o f P e d , B a l t . MD. 13 p a t i e n t s w i t h c o m p l e t e d e f i c i e n c i e s o f CPS o r OTC w e r e t r e a t e d f o r w i t h a low p r o t e i n , e s s e n t i a l amino a c i d ( E A A ) d i e t p l u s a r g i n i n e ( A r g ) o r c i t r u ll i n e ( C i t ) ( l r n m o l / k g ) p l u s 250 mg/kg o f b e n z o a t e ( B ) ( R e g imen I ) . 5 o f t h e s e p a t i e n t s d i e d d u r i n g 11 p a t i e n t y e a r s o f t h e r a p y . P h e n y l a c e t a t e ( P ) ( 2 5 0 mg/kg)was a d d e d i n 12 p a t i e n t s (Regimen 1 1 ) f o r 14 p a t i e n t y e a r s , d u r i n g w h i c h o n e p a t i e n t d i e d d u e t o a n o v e r d o s e o f B a n d P. P a r t i t i o n o f u r i n a r y n i t r o g e n (PUN) i n 5 s u c h p a t i e n t s r e v e a l e d t h a t hippurate-N(HAN) and p h e n y l a c et y l g l u t a m i n e -N (PAGN) r e s p e c t i v e l y a c c o u n t e d f o r ( m k S D ) 2 1 . 8 k 4 . 2 and 3 8 . 2 k 8 . 1 % o f e f f e c t i v e u r i n a r y w a s t e n i t r o g e n (EWN)for a t o t a l o f 60%. 7 p a t i e n t s w i t h ASA s y n t h e t a s e d e f i c i e n c y (AS) w e r e t r e a t e d w i t h Regimen I p l u s a d d i t i o n a l Arg t o s u p p l y 2-4 mmol k g / d (Regimen 1 1 1 ) f o r 1 8 . 4 p a t i e n t y e a r s ; o n e p a t i e n t d i e d . Regimen
I11 was m o d i f i e d by s u b s t i t u t i n g p r o t e i n f o r t h e EAA a n d a d d i n g P f o r 3 p a t i e n t y e a r s w i t h n o d e a t h s . PUN i n 3 AS c h i l d r e n r e v e a l e d t h a t HAN, PAGN and Cit-N a c c o u n t e d
f o r 1 7 , 22 a n d 12% o f EWN f o r a t o t a l o f 5 1 % . 17 p a t i e n t s w i t h A L d e f i c i e n c y w e r e t r e a t e d w i t h 1.5-2.0 g / d o f p r o t e i n s u p p l e m e n t e d w i t h 2-4 rnmol/kg Arg f o r 37 p a t i e n t y e a r s ;
o n e d i e d . ASA-N a c c o u n t e d f o r 5 4 % o f E W N i n 2 p a t i e n t s .
T h u s HAN, PAGN, Cit-N and ASA-N a r e a d e q u a t e EWN s u b s t i t u t e s f o r u r e a and s u p p o r t l i f e i n t h e s e o t h e r w i s e f a t a l d i s e a s e s .
CARRIER FREQUENCIES FOR SANDHOFF DISEASE (SHD) AND

TAY-SACHS (TSD) I N AMERICAN JEWISH ( J ) AND NON-JEWISH
(NJ) POPULATIONS. R . Cantor, J . Lim, C. Roy, M. Kirk, M. Kaback, Harbor-UCLA Med. C t r . , Dept. P e d i a t r i c s , Torrance, CA.
Serum hexosaminidase (HEX) p r o f i l e s from 59,805 J and 42,477 N J individuals screened f o r TSD heterozygote s t a t u s were used t o estimate t h e SHD and TSD c a r r i e r frequencies i n t h e s e populations. * nMoles 4MU produced/hour/ml. serum A 95% b i v a r i a t e isodensity e l l i p s e has been constructed with T-HEX and % HM-A values from 31 o b l i g a t e SKD heterozygotes. The e l l i p s e i d e n t i f i e s suspect SHD C with 95% s e n s i t i v i t y and a 1-3% f a l s e p o s i t i v e r a t e . Cluster a n a l y s i s and a derived l i n e a r discriminant function from r e t e s t serum and leukocyte T-HEX and % HEX-A values discriminates between t r u e SHD C and NC. The SHD C frequency i s 11801 i n J and 1/414 i n N J . These estimates a r e consistent with SHD incidence d a t a from our national surveillance program. The TSD C frequency i n J i s 1/28, while a TSD C r a t e i n N J of 1/90 has been observed. The N J TSD C r a t e i s not consist e n t with disease incidence data. Rather, i t i s probable t h a t 70% of t h e N J i d e n t i f i e d a s TSD C may be heterozygotes f o r other p a r t i a l HEX-A mutations, and t h e r e f o r e a t r i s k f o r other GM2 ganglioside storage disorders.
DYSMORPHI C SYNDROME. SPHEROCYTOSI S All0 PARTIAL DELE-
? 748 TION OF THE SHORT ARM OF CHROMOSOME 8. Robert RT Chilcote, Barbara Jones, Carlton Dampier, Michelle LeBeau, Janet Row ley, Yury Verl insky , a n d g a g e n e o n . Marc 0. Beem), The University of Chicago, Wyler Children's Hospit a l and Michael Reese Hospital, Chicago, I L Congenital spherocytic anemia i s a r e l a t i v e l y common disorder but the genetic defect has not yet been d e f i n i t i v e l y mapped t o a chromosome. W e studied a family in which 2 of 3 children were dysmrphic, affected by severe spherocytosis requiring intermitt a n t t r a n s f u s i o n s , and showed d e l e t i o n of a portion of the short arm of chromosome 8 (8p-). Both parents and the s i b l i n g were normal and showed no evidence of hemolysis or the d e l e t i o n . Assays of carbonic anhydrase I I , f a c t o r VII, thryroglobulin, and glutathione reductase, genes previously assigned to 8p were unremarkable.
In order to e l u c i d a t e the membrane d e f e c t , red c e l l membranes were electrophoresed using I -D Fairbanks SDS polyacrylamide gels and a modified O I F a r r e l l 2-D technique. Lipids were examined using thin-layer chromatography. Coomasie blue stained I -D and s i lver stained 2-D electrophoretograms were normal ; in p a r t i c u l a r members of the ternary binding complex, s p e c t r i n ( a and B ) , band 4.1, and a c t i n were normal as were membrane chole s t e r o l and phospholipids. The association between the gene deletion and spherocytosis in the a f f e c t e d family members suggests t h a t a gene f o r t h i s defect l i e s on 8p, but does not a f f e c t the q u a n t i t i e s of membrane proteins conventionally associated with rec c e l l membrane s t a b i l i t y .
DEFECTIVE CHYLOMICRON REMNANT CLEARANCE IN PATIENTS
749 WITH FAMILIAL OYSBETALIPOPROTEINEMIA. d e a n . Center. Children's Hosoital of Philadelohia. Philadelohia. P A mi i i a1 dysbetalipoproteinemia r e s u l t s in p a r t from a genetic defect in apolipoprotein E (apoE) which prevents normal binding of chylomicron remnants t o a s p e c i f i c hepatic apoE receptor. W e have developed a technique f o r measuring t h e consequent abnormality i n chylomicron remnant clearance i n t h e s e p a t i e n t s . Oral administration of r e t i n o l and Lipomul permits t h e label ling of nascent chylomicrons with r e t i n y l palmitate (RP). RP i s measured by high pressure l i q u i d chromatography in plasma and i n i s o l a t e d lipoprotein f r a c t i o n s from 10-12 hourly blood samples. Clearance of chylomicron remnants ( T q i s calculated from t h e r a t e of disappearance of RP from chylomicrons and very low density lipoproteins. The method was found t o be s a f e and without s i d e e f f e c t s in 45 a d u l t s . Chylomicron remnant T4was 1.5i0.5 hours i n 7 people with normal f a s t i n g l i p i d s . There was no change i n low density lipoprotein RP; no RP was found in high density lipoprotein; no exchange of RP between lipoproteins was found. Five p a t i e n t s with f a m i l i a l dysbetalipoproteinemia were studied, including a teenage boy homozygous f o r t h e apoE 2 genetic variant (apoE 2/2) with severe type I11 hyperlipoproteinemi a , generalized p r u r i t i c tuberoeruptive xanthorna and xanthoma s t r i a t a palmaris. All p a t i e n t s f a i l e d t o c l e a r RP during t h e t e s t , consistent with t h e f a i l u r e of hepatic upake of chylomicron remnants carrying t h i s apoE v a r i a n t .
